Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Drugs for Herpes Labialis (Oral Herpes) Market 2018, Forecast to 2023
Herpes Labialis (Oral Herpes) is a type of herpes simplex occurring on the lip, i.e. an infection caused by herpes simplex virus (HSV). An outbreak typically causes small blisters or sores on or around the mouth. The sores typically heal within 2–3 weeks, but the herpes virus remains dormant in the facial nerves, following orofacial infection, periodically reactivating (in symptomatic people) to create sores in the same area of the mouth or face at the site of the original infection.
SCOPE OF THE REPORT:
This report focuses on the Drugs for Herpes Labialis (Oral Herpes) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Herpes Simplex Virus (HSV) is a commonly found human pathogen. Globally, an estimated 4.0 billion people are infected with Herpes Virus. The incidence rate of cold sores, caused by the HSV1 virus, is the second largest worldwide, trailing only behind common cold. About 79% of the US population is infected with HSV1, with about 25-35% of the adults enduring recurrent spate of cold sores. In all, close to 100 million outbreaks of cold sores occur each year in the US.
The classification of drugs for herpes labialis (oral herpes) includes valacyclovir, aciclovir, famciclovir, docosanol and other. The proportion of aciclovir in 2016 is about 17%, and the proportion of valacyclovir is about 45%.
Drugs for herpes labialis (oral herpes) are widely used though external use, oral and injection. The most proportion of drugs for herpes labialis (oral herpes) is oral, and the consumption in 2016 is about 1200 M USD.
North America is the largest consumption place, with a revenue market share nearly 36.5% in 2016. Following North America, Europe is the second largest consumption place with the revenue market share of 28.4%.
Market competition is intense. GSK, Novartis, Teva, Mylan, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Drugs for Herpes Labialis (Oral Herpes) is expected to grow at a CAGR of roughly 4.9% over the next five years, will reach 2710 million US$ in 2023, from 2040 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Chapter 1, to describe Drugs for Herpes Labialis (Oral Herpes) Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Drugs for Herpes Labialis (Oral Herpes), with sales, revenue, and price of Drugs for Herpes Labialis (Oral Herpes), in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Drugs for Herpes Labialis (Oral Herpes), for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Drugs for Herpes Labialis (Oral Herpes) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Drugs for Herpes Labialis (Oral Herpes) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
SCOPE OF THE REPORT:
This report focuses on the Drugs for Herpes Labialis (Oral Herpes) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Herpes Simplex Virus (HSV) is a commonly found human pathogen. Globally, an estimated 4.0 billion people are infected with Herpes Virus. The incidence rate of cold sores, caused by the HSV1 virus, is the second largest worldwide, trailing only behind common cold. About 79% of the US population is infected with HSV1, with about 25-35% of the adults enduring recurrent spate of cold sores. In all, close to 100 million outbreaks of cold sores occur each year in the US.
The classification of drugs for herpes labialis (oral herpes) includes valacyclovir, aciclovir, famciclovir, docosanol and other. The proportion of aciclovir in 2016 is about 17%, and the proportion of valacyclovir is about 45%.
Drugs for herpes labialis (oral herpes) are widely used though external use, oral and injection. The most proportion of drugs for herpes labialis (oral herpes) is oral, and the consumption in 2016 is about 1200 M USD.
North America is the largest consumption place, with a revenue market share nearly 36.5% in 2016. Following North America, Europe is the second largest consumption place with the revenue market share of 28.4%.
Market competition is intense. GSK, Novartis, Teva, Mylan, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Drugs for Herpes Labialis (Oral Herpes) is expected to grow at a CAGR of roughly 4.9% over the next five years, will reach 2710 million US$ in 2023, from 2040 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- GSK
- Novartis
- Teva
- Mylan
- Cadila
- Apotex
- Daewoong Pharmaceutical
- Livzon
- Luoxin
- Med shine
- Bayer (Campho Phenique)
- Blistex
- Kelun Group
- Hikma
- Haiwang
- Carmex
- Cipher
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- Aciclovir
- Valacyclovir
- Famciclovir
- Docosanol
- Other
- External Use
- Oral
- Injection
Chapter 1, to describe Drugs for Herpes Labialis (Oral Herpes) Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Drugs for Herpes Labialis (Oral Herpes), with sales, revenue, and price of Drugs for Herpes Labialis (Oral Herpes), in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Drugs for Herpes Labialis (Oral Herpes), for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Drugs for Herpes Labialis (Oral Herpes) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Drugs for Herpes Labialis (Oral Herpes) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
1 MARKET OVERVIEW
1.1 Drugs for Herpes Labialis (Oral Herpes) Introduction
1.2 Market Analysis by Type
1.2.1 Aciclovir
1.2.2 Valacyclovir
1.2.3 Famciclovir
1.2.4 Docosanol
1.2.5 Other
1.3 Market Analysis by Applications
1.3.1 External Use
1.3.2 Oral
1.3.3 Injection
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 GSK
2.1.1 Business Overview
2.1.1.1 GSK Description
2.1.1.2 GSK Headquarter, Main Business and Finance Overview
2.1.2 GSK Drugs for Herpes Labialis (Oral Herpes) Product Introduction
2.1.2.1 Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
2.1.2.2 Drugs for Herpes Labialis (Oral Herpes) Product Information
2.1.3 GSK Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 GSK Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global GSK Drugs for Herpes Labialis (Oral Herpes) Market Share in 2017
2.2 Novartis
2.2.1 Business Overview
2.2.1.1 Novartis Description
2.2.1.2 Novartis Headquarter, Main Business and Finance Overview
2.2.2 Novartis Drugs for Herpes Labialis (Oral Herpes) Product Introduction
2.2.2.1 Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
2.2.2.2 Drugs for Herpes Labialis (Oral Herpes) Product Information
2.2.3 Novartis Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Novartis Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Novartis Drugs for Herpes Labialis (Oral Herpes) Market Share in 2017
2.3 Teva
2.3.1 Business Overview
2.3.1.1 Teva Description
2.3.1.2 Teva Headquarter, Main Business and Finance Overview
2.3.2 Teva Drugs for Herpes Labialis (Oral Herpes) Product Introduction
2.3.2.1 Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
2.3.2.2 Drugs for Herpes Labialis (Oral Herpes) Product Information
2.3.3 Teva Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Teva Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Teva Drugs for Herpes Labialis (Oral Herpes) Market Share in 2017
2.4 Mylan
2.4.1 Business Overview
2.4.1.1 Mylan Description
2.4.1.2 Mylan Headquarter, Main Business and Finance Overview
2.4.2 Mylan Drugs for Herpes Labialis (Oral Herpes) Product Introduction
2.4.2.1 Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
2.4.2.2 Drugs for Herpes Labialis (Oral Herpes) Product Information
2.4.3 Mylan Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Mylan Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Mylan Drugs for Herpes Labialis (Oral Herpes) Market Share in 2017
2.5 Cadila
2.5.1 Business Overview
2.5.1.1 Cadila Description
2.5.1.2 Cadila Headquarter, Main Business and Finance Overview
2.5.2 Cadila Drugs for Herpes Labialis (Oral Herpes) Product Introduction
2.5.2.1 Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
2.5.2.2 Drugs for Herpes Labialis (Oral Herpes) Product Information
2.5.3 Cadila Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Cadila Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Cadila Drugs for Herpes Labialis (Oral Herpes) Market Share in 2017
2.6 Apotex
2.6.1 Business Overview
2.6.1.1 Apotex Description
2.6.1.2 Apotex Headquarter, Main Business and Finance Overview
2.6.2 Apotex Drugs for Herpes Labialis (Oral Herpes) Product Introduction
2.6.2.1 Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
2.6.2.2 Drugs for Herpes Labialis (Oral Herpes) Product Information
2.6.3 Apotex Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Apotex Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Apotex Drugs for Herpes Labialis (Oral Herpes) Market Share in 2017
2.7 Daewoong Pharmaceutical
2.7.1 Business Overview
2.7.1.1 Daewoong Pharmaceutical Description
2.7.1.2 Daewoong Pharmaceutical Headquarter, Main Business and Finance Overview
2.7.2 Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Product Introduction
2.7.2.1 Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
2.7.2.2 Drugs for Herpes Labialis (Oral Herpes) Product Information
2.7.3 Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Market Share in 2017
2.8 Livzon
2.8.1 Business Overview
2.8.1.1 Livzon Description
2.8.1.2 Livzon Headquarter, Main Business and Finance Overview
2.8.2 Livzon Drugs for Herpes Labialis (Oral Herpes) Product Introduction
2.8.2.1 Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
2.8.2.2 Drugs for Herpes Labialis (Oral Herpes) Product Information
2.8.3 Livzon Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Livzon Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Livzon Drugs for Herpes Labialis (Oral Herpes) Market Share in 2017
2.9 Luoxin
2.9.1 Business Overview
2.9.1.1 Luoxin Description
2.9.1.2 Luoxin Headquarter, Main Business and Finance Overview
2.9.2 Luoxin Drugs for Herpes Labialis (Oral Herpes) Product Introduction
2.9.2.1 Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
2.9.2.2 Drugs for Herpes Labialis (Oral Herpes) Product Information
2.9.3 Luoxin Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Luoxin Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Luoxin Drugs for Herpes Labialis (Oral Herpes) Market Share in 2017
2.10 Med shine
2.10.1 Business Overview
2.10.1.1 Med shine Description
2.10.1.2 Med shine Headquarter, Main Business and Finance Overview
2.10.2 Med shine Drugs for Herpes Labialis (Oral Herpes) Product Introduction
2.10.2.1 Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
2.10.2.2 Drugs for Herpes Labialis (Oral Herpes) Product Information
2.10.3 Med shine Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Med shine Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Med shine Drugs for Herpes Labialis (Oral Herpes) Market Share in 2017
2.11 Bayer (Campho Phenique)
2.11.1 Business Overview
2.11.2 Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Product Introduction
2.11.3 Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Blistex
2.12.1 Business Overview
2.12.2 Blistex Drugs for Herpes Labialis (Oral Herpes) Product Introduction
2.12.3 Blistex Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Kelun Group
2.13.1 Business Overview
2.13.2 Kelun Group Drugs for Herpes Labialis (Oral Herpes) Product Introduction
2.13.3 Kelun Group Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Hikma
2.14.1 Business Overview
2.14.2 Hikma Drugs for Herpes Labialis (Oral Herpes) Product Introduction
2.14.3 Hikma Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Haiwang
2.15.1 Business Overview
2.15.2 Haiwang Drugs for Herpes Labialis (Oral Herpes) Product Introduction
2.15.3 Haiwang Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Carmex
2.16.1 Business Overview
2.16.2 Carmex Drugs for Herpes Labialis (Oral Herpes) Product Introduction
2.16.3 Carmex Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Cipher
2.17.1 Business Overview
2.17.2 Cipher Drugs for Herpes Labialis (Oral Herpes) Product Introduction
2.17.3 Cipher Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL DRUGS FOR HERPES LABIALIS (ORAL HERPES) MARKET COMPETITION, BY MANUFACTURER
3.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Drugs for Herpes Labialis (Oral Herpes) Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Drugs for Herpes Labialis (Oral Herpes) Manufacturer Market Share in 2017
3.4.2 Top 5 Drugs for Herpes Labialis (Oral Herpes) Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 GLOBAL DRUGS FOR HERPES LABIALIS (ORAL HERPES) MARKET ANALYSIS BY REGIONS
4.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Regions
4.1.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales by Regions (2013-2018)
4.1.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue by Regions (2013-2018)
4.2 North America Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA DRUGS FOR HERPES LABIALIS (ORAL HERPES) BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
5.1 North America Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Countries
5.1.1 North America Drugs for Herpes Labialis (Oral Herpes) Sales by Countries (2013-2018)
5.1.2 North America Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries (2013-2018)
5.1.3 United States Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
5.1.4 Canada Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
5.1.5 Mexico Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
5.2 North America Drugs for Herpes Labialis (Oral Herpes) Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Drugs for Herpes Labialis (Oral Herpes) Sales by Manufacturers (2016-2017)
5.2.2 North America Drugs for Herpes Labialis (Oral Herpes) Revenue by Manufacturers (2016-2017)
5.3 North America Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Drugs for Herpes Labialis (Oral Herpes) Sales and Sales Share by Type (2013-2018)
5.3.2 North America Drugs for Herpes Labialis (Oral Herpes) Revenue and Revenue Share by Type (2013-2018)
5.4 North America Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Drugs for Herpes Labialis (Oral Herpes) Sales and Sales Share by Application (2013-2018)
5.4.2 North America Drugs for Herpes Labialis (Oral Herpes) Revenue and Revenue Share by Application (2013-2018)
6 EUROPE DRUGS FOR HERPES LABIALIS (ORAL HERPES) BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
6.1 Europe Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Countries
6.1.1 Europe Drugs for Herpes Labialis (Oral Herpes) Sales by Countries (2013-2018)
6.1.2 Europe Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries (2013-2018)
6.1.3 Germany Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
6.1.4 UK Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
6.1.5 France Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
6.1.6 Russia Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
6.1.7 Italy Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
6.2 Europe Drugs for Herpes Labialis (Oral Herpes) Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Drugs for Herpes Labialis (Oral Herpes) Sales by Manufacturers (2016-2017)
6.2.2 Europe Drugs for Herpes Labialis (Oral Herpes) Revenue by Manufacturers (2016-2017)
6.3 Europe Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Drugs for Herpes Labialis (Oral Herpes) Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Drugs for Herpes Labialis (Oral Herpes) Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Drugs for Herpes Labialis (Oral Herpes) Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Drugs for Herpes Labialis (Oral Herpes) Revenue and Revenue Share by Application (2013-2018)
7 ASIA-PACIFIC DRUGS FOR HERPES LABIALIS (ORAL HERPES) BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
7.1 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries (2013-2018)
7.1.3 China Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
7.1.4 Japan Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
7.1.5 Korea Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
7.1.6 India Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue and Revenue Share by Application (2013-2018)
8 SOUTH AMERICA DRUGS FOR HERPES LABIALIS (ORAL HERPES) BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
8.1 South America Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Countries
8.1.1 South America Drugs for Herpes Labialis (Oral Herpes) Sales by Countries (2013-2018)
8.1.2 South America Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries (2013-2018)
8.1.3 Brazil Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
8.1.4 Argentina Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
8.1.5 Colombia Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
8.2 South America Drugs for Herpes Labialis (Oral Herpes) Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Drugs for Herpes Labialis (Oral Herpes) Sales by Manufacturers (2016-2017)
8.2.2 South America Drugs for Herpes Labialis (Oral Herpes) Revenue by Manufacturers (2016-2017)
8.3 South America Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Drugs for Herpes Labialis (Oral Herpes) Sales and Sales Share by Type (2013-2018)
8.3.2 South America Drugs for Herpes Labialis (Oral Herpes) Revenue and Revenue Share by Type (2013-2018)
8.4 South America Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Drugs for Herpes Labialis (Oral Herpes) Sales and Sales Share by Application (2013-2018)
8.4.2 South America Drugs for Herpes Labialis (Oral Herpes) Revenue and Revenue Share by Application (2013-2018)
9 MIDDLE EAST AND AFRICA DRUGS FOR HERPES LABIALIS (ORAL HERPES) BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
9.1 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
9.1.4 UAE Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
9.1.5 Egypt Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
9.1.7 South Africa Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue and Revenue Share by Application (2013-2018)
10 GLOBAL DRUGS FOR HERPES LABIALIS (ORAL HERPES) MARKET SEGMENT BY TYPE
10.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales and Market Share by Type (2013-2018)
10.1.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Type (2013-2018)
10.2 Aciclovir Sales Growth and Price
10.2.1 Global Aciclovir Sales Growth (2013-2018)
10.2.2 Global Aciclovir Price (2013-2018)
10.3 Valacyclovir Sales Growth and Price
10.3.1 Global Valacyclovir Sales Growth (2013-2018)
10.3.2 Global Valacyclovir Price (2013-2018)
10.4 Famciclovir Sales Growth and Price
10.4.1 Global Famciclovir Sales Growth (2013-2018)
10.4.2 Global Famciclovir Price (2013-2018)
10.5 Docosanol Sales Growth and Price
10.5.1 Global Docosanol Sales Growth (2013-2018)
10.5.2 Global Docosanol Price (2013-2018)
10.6 Other Sales Growth and Price
10.6.1 Global Other Sales Growth (2013-2018)
10.6.2 Global Other Price (2013-2018)
11 GLOBAL DRUGS FOR HERPES LABIALIS (ORAL HERPES) MARKET SEGMENT BY APPLICATION
11.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application (2013-2018)
11.2 External Use Sales Growth (2013-2018)
11.3 Oral Sales Growth (2013-2018)
11.4 Injection Sales Growth (2013-2018)
12 DRUGS FOR HERPES LABIALIS (ORAL HERPES) MARKET FORECAST (2018-2023)
12.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Growth Rate (2018-2023)
12.2 Drugs for Herpes Labialis (Oral Herpes) Market Forecast by Regions (2018-2023)
12.2.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Forecast (2018-2023)
12.2.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Forecast (2018-2023)
12.2.3 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Forecast (2018-2023)
12.2.4 South America Drugs for Herpes Labialis (Oral Herpes) Market Forecast (2018-2023)
12.2.5 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Market Forecast (2018-2023)
12.3 Drugs for Herpes Labialis (Oral Herpes) Market Forecast by Type (2018-2023)
12.3.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales Forecast by Type (2018-2023)
12.3.2 Global Drugs for Herpes Labialis (Oral Herpes) Market Share Forecast by Type (2018-2023)
12.4 Drugs for Herpes Labialis (Oral Herpes) Market Forecast by Application (2018-2023)
12.4.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales Forecast by Application (2018-2023)
12.4.2 Global Drugs for Herpes Labialis (Oral Herpes) Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
1.1 Drugs for Herpes Labialis (Oral Herpes) Introduction
1.2 Market Analysis by Type
1.2.1 Aciclovir
1.2.2 Valacyclovir
1.2.3 Famciclovir
1.2.4 Docosanol
1.2.5 Other
1.3 Market Analysis by Applications
1.3.1 External Use
1.3.2 Oral
1.3.3 Injection
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 GSK
2.1.1 Business Overview
2.1.1.1 GSK Description
2.1.1.2 GSK Headquarter, Main Business and Finance Overview
2.1.2 GSK Drugs for Herpes Labialis (Oral Herpes) Product Introduction
2.1.2.1 Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
2.1.2.2 Drugs for Herpes Labialis (Oral Herpes) Product Information
2.1.3 GSK Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 GSK Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global GSK Drugs for Herpes Labialis (Oral Herpes) Market Share in 2017
2.2 Novartis
2.2.1 Business Overview
2.2.1.1 Novartis Description
2.2.1.2 Novartis Headquarter, Main Business and Finance Overview
2.2.2 Novartis Drugs for Herpes Labialis (Oral Herpes) Product Introduction
2.2.2.1 Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
2.2.2.2 Drugs for Herpes Labialis (Oral Herpes) Product Information
2.2.3 Novartis Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Novartis Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Novartis Drugs for Herpes Labialis (Oral Herpes) Market Share in 2017
2.3 Teva
2.3.1 Business Overview
2.3.1.1 Teva Description
2.3.1.2 Teva Headquarter, Main Business and Finance Overview
2.3.2 Teva Drugs for Herpes Labialis (Oral Herpes) Product Introduction
2.3.2.1 Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
2.3.2.2 Drugs for Herpes Labialis (Oral Herpes) Product Information
2.3.3 Teva Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Teva Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Teva Drugs for Herpes Labialis (Oral Herpes) Market Share in 2017
2.4 Mylan
2.4.1 Business Overview
2.4.1.1 Mylan Description
2.4.1.2 Mylan Headquarter, Main Business and Finance Overview
2.4.2 Mylan Drugs for Herpes Labialis (Oral Herpes) Product Introduction
2.4.2.1 Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
2.4.2.2 Drugs for Herpes Labialis (Oral Herpes) Product Information
2.4.3 Mylan Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Mylan Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Mylan Drugs for Herpes Labialis (Oral Herpes) Market Share in 2017
2.5 Cadila
2.5.1 Business Overview
2.5.1.1 Cadila Description
2.5.1.2 Cadila Headquarter, Main Business and Finance Overview
2.5.2 Cadila Drugs for Herpes Labialis (Oral Herpes) Product Introduction
2.5.2.1 Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
2.5.2.2 Drugs for Herpes Labialis (Oral Herpes) Product Information
2.5.3 Cadila Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Cadila Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Cadila Drugs for Herpes Labialis (Oral Herpes) Market Share in 2017
2.6 Apotex
2.6.1 Business Overview
2.6.1.1 Apotex Description
2.6.1.2 Apotex Headquarter, Main Business and Finance Overview
2.6.2 Apotex Drugs for Herpes Labialis (Oral Herpes) Product Introduction
2.6.2.1 Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
2.6.2.2 Drugs for Herpes Labialis (Oral Herpes) Product Information
2.6.3 Apotex Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Apotex Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Apotex Drugs for Herpes Labialis (Oral Herpes) Market Share in 2017
2.7 Daewoong Pharmaceutical
2.7.1 Business Overview
2.7.1.1 Daewoong Pharmaceutical Description
2.7.1.2 Daewoong Pharmaceutical Headquarter, Main Business and Finance Overview
2.7.2 Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Product Introduction
2.7.2.1 Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
2.7.2.2 Drugs for Herpes Labialis (Oral Herpes) Product Information
2.7.3 Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Market Share in 2017
2.8 Livzon
2.8.1 Business Overview
2.8.1.1 Livzon Description
2.8.1.2 Livzon Headquarter, Main Business and Finance Overview
2.8.2 Livzon Drugs for Herpes Labialis (Oral Herpes) Product Introduction
2.8.2.1 Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
2.8.2.2 Drugs for Herpes Labialis (Oral Herpes) Product Information
2.8.3 Livzon Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Livzon Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Livzon Drugs for Herpes Labialis (Oral Herpes) Market Share in 2017
2.9 Luoxin
2.9.1 Business Overview
2.9.1.1 Luoxin Description
2.9.1.2 Luoxin Headquarter, Main Business and Finance Overview
2.9.2 Luoxin Drugs for Herpes Labialis (Oral Herpes) Product Introduction
2.9.2.1 Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
2.9.2.2 Drugs for Herpes Labialis (Oral Herpes) Product Information
2.9.3 Luoxin Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Luoxin Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Luoxin Drugs for Herpes Labialis (Oral Herpes) Market Share in 2017
2.10 Med shine
2.10.1 Business Overview
2.10.1.1 Med shine Description
2.10.1.2 Med shine Headquarter, Main Business and Finance Overview
2.10.2 Med shine Drugs for Herpes Labialis (Oral Herpes) Product Introduction
2.10.2.1 Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
2.10.2.2 Drugs for Herpes Labialis (Oral Herpes) Product Information
2.10.3 Med shine Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Med shine Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Med shine Drugs for Herpes Labialis (Oral Herpes) Market Share in 2017
2.11 Bayer (Campho Phenique)
2.11.1 Business Overview
2.11.2 Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Product Introduction
2.11.3 Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Blistex
2.12.1 Business Overview
2.12.2 Blistex Drugs for Herpes Labialis (Oral Herpes) Product Introduction
2.12.3 Blistex Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Kelun Group
2.13.1 Business Overview
2.13.2 Kelun Group Drugs for Herpes Labialis (Oral Herpes) Product Introduction
2.13.3 Kelun Group Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Hikma
2.14.1 Business Overview
2.14.2 Hikma Drugs for Herpes Labialis (Oral Herpes) Product Introduction
2.14.3 Hikma Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Haiwang
2.15.1 Business Overview
2.15.2 Haiwang Drugs for Herpes Labialis (Oral Herpes) Product Introduction
2.15.3 Haiwang Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Carmex
2.16.1 Business Overview
2.16.2 Carmex Drugs for Herpes Labialis (Oral Herpes) Product Introduction
2.16.3 Carmex Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Cipher
2.17.1 Business Overview
2.17.2 Cipher Drugs for Herpes Labialis (Oral Herpes) Product Introduction
2.17.3 Cipher Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL DRUGS FOR HERPES LABIALIS (ORAL HERPES) MARKET COMPETITION, BY MANUFACTURER
3.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Drugs for Herpes Labialis (Oral Herpes) Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Drugs for Herpes Labialis (Oral Herpes) Manufacturer Market Share in 2017
3.4.2 Top 5 Drugs for Herpes Labialis (Oral Herpes) Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 GLOBAL DRUGS FOR HERPES LABIALIS (ORAL HERPES) MARKET ANALYSIS BY REGIONS
4.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Regions
4.1.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales by Regions (2013-2018)
4.1.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue by Regions (2013-2018)
4.2 North America Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA DRUGS FOR HERPES LABIALIS (ORAL HERPES) BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
5.1 North America Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Countries
5.1.1 North America Drugs for Herpes Labialis (Oral Herpes) Sales by Countries (2013-2018)
5.1.2 North America Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries (2013-2018)
5.1.3 United States Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
5.1.4 Canada Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
5.1.5 Mexico Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
5.2 North America Drugs for Herpes Labialis (Oral Herpes) Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Drugs for Herpes Labialis (Oral Herpes) Sales by Manufacturers (2016-2017)
5.2.2 North America Drugs for Herpes Labialis (Oral Herpes) Revenue by Manufacturers (2016-2017)
5.3 North America Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Drugs for Herpes Labialis (Oral Herpes) Sales and Sales Share by Type (2013-2018)
5.3.2 North America Drugs for Herpes Labialis (Oral Herpes) Revenue and Revenue Share by Type (2013-2018)
5.4 North America Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Drugs for Herpes Labialis (Oral Herpes) Sales and Sales Share by Application (2013-2018)
5.4.2 North America Drugs for Herpes Labialis (Oral Herpes) Revenue and Revenue Share by Application (2013-2018)
6 EUROPE DRUGS FOR HERPES LABIALIS (ORAL HERPES) BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
6.1 Europe Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Countries
6.1.1 Europe Drugs for Herpes Labialis (Oral Herpes) Sales by Countries (2013-2018)
6.1.2 Europe Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries (2013-2018)
6.1.3 Germany Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
6.1.4 UK Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
6.1.5 France Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
6.1.6 Russia Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
6.1.7 Italy Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
6.2 Europe Drugs for Herpes Labialis (Oral Herpes) Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Drugs for Herpes Labialis (Oral Herpes) Sales by Manufacturers (2016-2017)
6.2.2 Europe Drugs for Herpes Labialis (Oral Herpes) Revenue by Manufacturers (2016-2017)
6.3 Europe Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Drugs for Herpes Labialis (Oral Herpes) Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Drugs for Herpes Labialis (Oral Herpes) Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Drugs for Herpes Labialis (Oral Herpes) Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Drugs for Herpes Labialis (Oral Herpes) Revenue and Revenue Share by Application (2013-2018)
7 ASIA-PACIFIC DRUGS FOR HERPES LABIALIS (ORAL HERPES) BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
7.1 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries (2013-2018)
7.1.3 China Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
7.1.4 Japan Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
7.1.5 Korea Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
7.1.6 India Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue and Revenue Share by Application (2013-2018)
8 SOUTH AMERICA DRUGS FOR HERPES LABIALIS (ORAL HERPES) BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
8.1 South America Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Countries
8.1.1 South America Drugs for Herpes Labialis (Oral Herpes) Sales by Countries (2013-2018)
8.1.2 South America Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries (2013-2018)
8.1.3 Brazil Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
8.1.4 Argentina Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
8.1.5 Colombia Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
8.2 South America Drugs for Herpes Labialis (Oral Herpes) Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Drugs for Herpes Labialis (Oral Herpes) Sales by Manufacturers (2016-2017)
8.2.2 South America Drugs for Herpes Labialis (Oral Herpes) Revenue by Manufacturers (2016-2017)
8.3 South America Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Drugs for Herpes Labialis (Oral Herpes) Sales and Sales Share by Type (2013-2018)
8.3.2 South America Drugs for Herpes Labialis (Oral Herpes) Revenue and Revenue Share by Type (2013-2018)
8.4 South America Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Drugs for Herpes Labialis (Oral Herpes) Sales and Sales Share by Application (2013-2018)
8.4.2 South America Drugs for Herpes Labialis (Oral Herpes) Revenue and Revenue Share by Application (2013-2018)
9 MIDDLE EAST AND AFRICA DRUGS FOR HERPES LABIALIS (ORAL HERPES) BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
9.1 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
9.1.4 UAE Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
9.1.5 Egypt Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
9.1.7 South Africa Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue and Revenue Share by Application (2013-2018)
10 GLOBAL DRUGS FOR HERPES LABIALIS (ORAL HERPES) MARKET SEGMENT BY TYPE
10.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales and Market Share by Type (2013-2018)
10.1.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Type (2013-2018)
10.2 Aciclovir Sales Growth and Price
10.2.1 Global Aciclovir Sales Growth (2013-2018)
10.2.2 Global Aciclovir Price (2013-2018)
10.3 Valacyclovir Sales Growth and Price
10.3.1 Global Valacyclovir Sales Growth (2013-2018)
10.3.2 Global Valacyclovir Price (2013-2018)
10.4 Famciclovir Sales Growth and Price
10.4.1 Global Famciclovir Sales Growth (2013-2018)
10.4.2 Global Famciclovir Price (2013-2018)
10.5 Docosanol Sales Growth and Price
10.5.1 Global Docosanol Sales Growth (2013-2018)
10.5.2 Global Docosanol Price (2013-2018)
10.6 Other Sales Growth and Price
10.6.1 Global Other Sales Growth (2013-2018)
10.6.2 Global Other Price (2013-2018)
11 GLOBAL DRUGS FOR HERPES LABIALIS (ORAL HERPES) MARKET SEGMENT BY APPLICATION
11.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Application (2013-2018)
11.2 External Use Sales Growth (2013-2018)
11.3 Oral Sales Growth (2013-2018)
11.4 Injection Sales Growth (2013-2018)
12 DRUGS FOR HERPES LABIALIS (ORAL HERPES) MARKET FORECAST (2018-2023)
12.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Growth Rate (2018-2023)
12.2 Drugs for Herpes Labialis (Oral Herpes) Market Forecast by Regions (2018-2023)
12.2.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Forecast (2018-2023)
12.2.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Forecast (2018-2023)
12.2.3 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Forecast (2018-2023)
12.2.4 South America Drugs for Herpes Labialis (Oral Herpes) Market Forecast (2018-2023)
12.2.5 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Market Forecast (2018-2023)
12.3 Drugs for Herpes Labialis (Oral Herpes) Market Forecast by Type (2018-2023)
12.3.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales Forecast by Type (2018-2023)
12.3.2 Global Drugs for Herpes Labialis (Oral Herpes) Market Share Forecast by Type (2018-2023)
12.4 Drugs for Herpes Labialis (Oral Herpes) Market Forecast by Application (2018-2023)
12.4.1 Global Drugs for Herpes Labialis (Oral Herpes) Sales Forecast by Application (2018-2023)
12.4.2 Global Drugs for Herpes Labialis (Oral Herpes) Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
LIST OF TABLES AND FIGURES
Figure Drugs for Herpes Labialis (Oral Herpes) Picture
Table Product Specifications of Drugs for Herpes Labialis (Oral Herpes)
Figure Global Drugs for Herpes Labialis (Oral Herpes) CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Drugs for Herpes Labialis (Oral Herpes) CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Drugs for Herpes Labialis (Oral Herpes) by Types in 2017
Figure Aciclovir Picture
Table Major Manufacturers of Aciclovir
Figure Valacyclovir Picture
Table Major Manufacturers of Valacyclovir
Figure Famciclovir Picture
Table Major Manufacturers of Famciclovir
Figure Docosanol Picture
Table Major Manufacturers of Docosanol
Figure Other Picture
Table Major Manufacturers of Other
Figure Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Applications in 2017
Figure External Use Picture
Figure Oral Picture
Figure Injection Picture
Figure United States Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Figure France Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Figure UK Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Figure China Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Figure India Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Table GSK Headquarter, Established, Main Business and Finance Overview (2017)
Table GSK Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
Table GSK Drugs for Herpes Labialis (Oral Herpes) Product
Table GSK Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global GSK Drugs for Herpes Labialis (Oral Herpes) Sales Market Share in 2017
Figure Global GSK Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share in 2017
Table Novartis Headquarter, Established, Main Business and Finance Overview (2017)
Table Novartis Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
Table Novartis Drugs for Herpes Labialis (Oral Herpes) Product
Table Novartis Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novartis Drugs for Herpes Labialis (Oral Herpes) Sales Market Share in 2017
Figure Global Novartis Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share in 2017
Table Teva Headquarter, Established, Main Business and Finance Overview (2017)
Table Teva Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
Table Teva Drugs for Herpes Labialis (Oral Herpes) Product
Table Teva Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Teva Drugs for Herpes Labialis (Oral Herpes) Sales Market Share in 2017
Figure Global Teva Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share in 2017
Table Mylan Headquarter, Established, Main Business and Finance Overview (2017)
Table Mylan Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
Table Mylan Drugs for Herpes Labialis (Oral Herpes) Product
Table Mylan Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Mylan Drugs for Herpes Labialis (Oral Herpes) Sales Market Share in 2017
Figure Global Mylan Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share in 2017
Table Cadila Headquarter, Established, Main Business and Finance Overview (2017)
Table Cadila Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
Table Cadila Drugs for Herpes Labialis (Oral Herpes) Product
Table Cadila Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Cadila Drugs for Herpes Labialis (Oral Herpes) Sales Market Share in 2017
Figure Global Cadila Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share in 2017
Table Apotex Headquarter, Established, Main Business and Finance Overview (2017)
Table Apotex Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
Table Apotex Drugs for Herpes Labialis (Oral Herpes) Product
Table Apotex Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Apotex Drugs for Herpes Labialis (Oral Herpes) Sales Market Share in 2017
Figure Global Apotex Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share in 2017
Table Daewoong Pharmaceutical Headquarter, Established, Main Business and Finance Overview (2017)
Table Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
Table Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Product
Table Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Sales Market Share in 2017
Figure Global Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share in 2017
Table Livzon Headquarter, Established, Main Business and Finance Overview (2017)
Table Livzon Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
Table Livzon Drugs for Herpes Labialis (Oral Herpes) Product
Table Livzon Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Livzon Drugs for Herpes Labialis (Oral Herpes) Sales Market Share in 2017
Figure Global Livzon Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share in 2017
Table Luoxin Headquarter, Established, Main Business and Finance Overview (2017)
Table Luoxin Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
Table Luoxin Drugs for Herpes Labialis (Oral Herpes) Product
Table Luoxin Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Luoxin Drugs for Herpes Labialis (Oral Herpes) Sales Market Share in 2017
Figure Global Luoxin Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share in 2017
Table Med shine Headquarter, Established, Main Business and Finance Overview (2017)
Table Med shine Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
Table Med shine Drugs for Herpes Labialis (Oral Herpes) Product
Table Med shine Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Med shine Drugs for Herpes Labialis (Oral Herpes) Sales Market Share in 2017
Figure Global Med shine Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share in 2017
Table Bayer (Campho Phenique)
Table Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes)
Table Blistex
Table Blistex Drugs for Herpes Labialis (Oral Herpes)
Table Kelun Group
Table Kelun Group Drugs for Herpes Labialis (Oral Herpes)
Table Hikma
Table Hikma Drugs for Herpes Labialis (Oral Herpes)
Table Haiwang
Table Haiwang Drugs for Herpes Labialis (Oral Herpes)
Table Carmex
Table Carmex Drugs for Herpes Labialis (Oral Herpes)
Table Cipher
Table Cipher Drugs for Herpes Labialis (Oral Herpes)
Table Global Drugs for Herpes Labialis (Oral Herpes) Sales by Manufacturer (2016-2017)
Figure Global Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Manufacturer in 2016
Figure Global Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Manufacturer in 2017
Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue by Manufacturer (2016-2017)
Figure Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Manufacturer in 2016
Figure Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Manufacturer in 2017
Table Global Drugs for Herpes Labialis (Oral Herpes) Price by Manufacturer (2016-2017)
Figure Top 3 Drugs for Herpes Labialis (Oral Herpes) Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Drugs for Herpes Labialis (Oral Herpes) Manufacturer (Revenue) Market Share in 2017
Figure Global Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure Global Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2013-2018)
Table Global Drugs for Herpes Labialis (Oral Herpes) Sales by Regions (2013-2018)
Table Global Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Regions (2013-2018)
Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue by Regions (2013-2018)
Figure Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Regions in 2013
Figure Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Regions in 2017
Figure North America Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure North America Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2013-2018)
Figure Europe Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure Europe Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2013-2018)
Figure South America Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure South America Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2013-2018)
Figure North America Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2013-2018)
Table North America Drugs for Herpes Labialis (Oral Herpes) Sales by Countries (2013-2018)
Table North America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Countries (2013-2018)
Figure North America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Countries in 2013
Figure North America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Countries in 2017
Table North America Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries (2013-2018)
Table North America Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Countries (2013-2018)
Figure North America Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Countries in 2013
Figure North America Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Countries in 2017
Figure United States Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure Canada Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure Mexico Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Table North America Drugs for Herpes Labialis (Oral Herpes) Sales by Manufacturer (2016-2017)
Figure North America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Manufacturer in 2016
Figure North America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Manufacturer in 2017
Table North America Drugs for Herpes Labialis (Oral Herpes) Revenue by Manufacturer (2016-2017)
Figure North America Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Manufacturer in 2016
Figure North America Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Manufacturer in 2017
Table North America Drugs for Herpes Labialis (Oral Herpes) Sales by Type (2013-2018)
Table North America Drugs for Herpes Labialis (Oral Herpes) Sales Share by Type (2013-2018)
Table North America Drugs for Herpes Labialis (Oral Herpes) Revenue by Type (2013-2018)
Table North America Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Type (2013-2018)
Table North America Drugs for Herpes Labialis (Oral Herpes) Sales by Application (2013-2018)
Table North America Drugs for Herpes Labialis (Oral Herpes) Sales Share by Application (2013-2018)
Table North America Drugs for Herpes Labialis (Oral Herpes) Revenue by Application (2013-2018)
Table North America Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Application (2013-2018)
Figure Europe Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2013-2018)
Table Europe Drugs for Herpes Labialis (Oral Herpes) Sales by Countries (2013-2018)
Table Europe Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Countries (2013-2018)
Table Europe Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries (2013-2018)
Figure Europe Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Countries in 2016
Figure Europe Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Countries in 2017
Figure Germany Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure UK Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure France Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure Russia Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure Italy Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Table Europe Drugs for Herpes Labialis (Oral Herpes) Sales by Manufacturer (2016-2017)
Figure Europe Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Manufacturer in 2016
Figure Europe Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Manufacturer in 2017
Table Europe Drugs for Herpes Labialis (Oral Herpes) Revenue by Manufacturer (2016-2017)
Figure Europe Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Manufacturer in 2016
Figure Europe Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Manufacturer in 2017
Table Europe Drugs for Herpes Labialis (Oral Herpes) Sales by Type (2013-2018)
Table Europe Drugs for Herpes Labialis (Oral Herpes) Sales Share by Type (2013-2018)
Table Europe Drugs for Herpes Labialis (Oral Herpes) Revenue by Type (2013-2018)
Table Europe Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Type (2013-2018)
Table Europe Drugs for Herpes Labialis (Oral Herpes) Sales by Application (2013-2018)
Table Europe Drugs for Herpes Labialis (Oral Herpes) Sales Share by Application (2013-2018)
Table Europe Drugs for Herpes Labialis (Oral Herpes) Revenue by Application (2013-2018)
Table Europe Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Application (2013-2018)
Figure Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales by Countries (2013-2018)
Table Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Countries 2017
Table Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries (2013-2018)
Figure Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Countries 2017
Figure China Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure Japan Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure Korea Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure India Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Table Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales by Type (2013-2018)
Table Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales Share by Type (2013-2018)
Table Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue by Type (2013-2018)
Table Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Type (2013-2018)
Table Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales by Application (2013-2018)
Table Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales Share by Application (2013-2018)
Table Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue by Application (2013-2018)
Table Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Application (2013-2018)
Figure South America Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2013-2018)
Table South America Drugs for Herpes Labialis (Oral Herpes) Sales by Countries (2013-2018)
Table South America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Countries (2013-2018)
Figure South America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Countries in 2017
Table South America Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries (2013-2018)
Table South America Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Countries (2013-2018)
Figure South America Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Countries in 2017
Figure Brazil Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure Argentina Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure Colombia Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Table South America Drugs for Herpes Labialis (Oral Herpes) Sales by Manufacturer (2016-2017)
Figure South America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Manufacturer in 2016
Figure South America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Manufacturer in 2017
Table South America Drugs for Herpes Labialis (Oral Herpes) Revenue by Manufacturer (2016-2017)
Figure South America Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Manufacturer in 2016
Figure South America Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Manufacturer in 2017
Table South America Drugs for Herpes Labialis (Oral Herpes) Sales by Type (2013-2018)
Table South America Drugs for Herpes Labialis (Oral Herpes) Sales Share by Type (2013-2018)
Table South America Drugs for Herpes Labialis (Oral Herpes) Revenue by Type (2013-2018)
Table South America Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Type (2013-2018)
Table South America Drugs for Herpes Labialis (Oral Herpes) Sales by Application (2013-2018)
Table South America Drugs for Herpes Labialis (Oral Herpes) Sales Share by Application (2013-2018)
Table South America Drugs for Herpes Labialis (Oral Herpes) Revenue by Application (2013-2018)
Table South America Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Application (2013-2018)
Figure Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales by Countries (2013-2018)
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Countries in 2017
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries (2013-2018)
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Countries in 2013
Figure Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Countries in 2017
Figure Saudi Arabia Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure UAE Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure Egypt Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure Nigeria Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure South Africa Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales by Type (2013-2018)
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales Share by Type (2013-2018)
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue by Type (2013-2018)
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Type (2013-2018)
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales by Application (2013-2018)
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales Share by Application (2013-2018)
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue by Application (2013-2018)
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Application (2013-2018)
Table Global Drugs for Herpes Labialis (Oral Herpes) Sales by Type (2013-2018)
Table Global Drugs for Herpes Labialis (Oral Herpes) Sales Share by Type (2013-2018)
Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue by Type (2013-2018)
Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Type (2013-2018)
Figure Global Aciclovir Sales Growth (2013-2018)
Figure Global Aciclovir Price (2013-2018)
Figure Global Valacyclovir Sales Growth (2013-2018)
Figure Global Valacyclovir Price (2013-2018)
Figure Global Famciclovir Sales Growth (2013-2018)
Figure Global Famciclovir Price (2013-2018)
Figure Global Docosanol Sales Growth (2013-2018)
Figure Global Docosanol Price (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Other Price (2013-2018)
Table Global Drugs for Herpes Labialis (Oral Herpes) Sales by Application (2013-2018)
Table Global Drugs for Herpes Labialis (Oral Herpes) Sales Share by Application (2013-2018)
Figure Global External Use Sales Growth (2013-2018)
Figure Global Oral Sales Growth (2013-2018)
Figure Global Injection Sales Growth (2013-2018)
Figure Global Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Growth Rate (2018-2023)
Table Global Drugs for Herpes Labialis (Oral Herpes) Sales Forecast by Regions (2018-2023)
Table Global Drugs for Herpes Labialis (Oral Herpes) Market Share Forecast by Regions (2018-2023)
Figure North America Sales Drugs for Herpes Labialis (Oral Herpes) Market Forecast (2018-2023)
Figure Europe Sales Drugs for Herpes Labialis (Oral Herpes) Market Forecast (2018-2023)
Figure Asia-Pacific Sales Drugs for Herpes Labialis (Oral Herpes) Market Forecast (2018-2023)
Figure South America Sales Drugs for Herpes Labialis (Oral Herpes) Market Forecast (2018-2023)
Figure Middle East and Africa Sales Drugs for Herpes Labialis (Oral Herpes) Market Forecast (2018-2023)
Table Global Drugs for Herpes Labialis (Oral Herpes) Sales Forecast by Type (2018-2023)
Table Global Drugs for Herpes Labialis (Oral Herpes) Market Share Forecast by Type (2018-2023)
Table Global Drugs for Herpes Labialis (Oral Herpes) Sales Forecast by Application (2018-2023)
Table Global Drugs for Herpes Labialis (Oral Herpes) Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
Figure Drugs for Herpes Labialis (Oral Herpes) Picture
Table Product Specifications of Drugs for Herpes Labialis (Oral Herpes)
Figure Global Drugs for Herpes Labialis (Oral Herpes) CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Drugs for Herpes Labialis (Oral Herpes) CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Drugs for Herpes Labialis (Oral Herpes) by Types in 2017
Figure Aciclovir Picture
Table Major Manufacturers of Aciclovir
Figure Valacyclovir Picture
Table Major Manufacturers of Valacyclovir
Figure Famciclovir Picture
Table Major Manufacturers of Famciclovir
Figure Docosanol Picture
Table Major Manufacturers of Docosanol
Figure Other Picture
Table Major Manufacturers of Other
Figure Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Applications in 2017
Figure External Use Picture
Figure Oral Picture
Figure Injection Picture
Figure United States Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Figure France Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Figure UK Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Figure China Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Figure India Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Drugs for Herpes Labialis (Oral Herpes) Revenue (Value) and Growth Rate (2013-2023)
Table GSK Headquarter, Established, Main Business and Finance Overview (2017)
Table GSK Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
Table GSK Drugs for Herpes Labialis (Oral Herpes) Product
Table GSK Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global GSK Drugs for Herpes Labialis (Oral Herpes) Sales Market Share in 2017
Figure Global GSK Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share in 2017
Table Novartis Headquarter, Established, Main Business and Finance Overview (2017)
Table Novartis Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
Table Novartis Drugs for Herpes Labialis (Oral Herpes) Product
Table Novartis Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novartis Drugs for Herpes Labialis (Oral Herpes) Sales Market Share in 2017
Figure Global Novartis Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share in 2017
Table Teva Headquarter, Established, Main Business and Finance Overview (2017)
Table Teva Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
Table Teva Drugs for Herpes Labialis (Oral Herpes) Product
Table Teva Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Teva Drugs for Herpes Labialis (Oral Herpes) Sales Market Share in 2017
Figure Global Teva Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share in 2017
Table Mylan Headquarter, Established, Main Business and Finance Overview (2017)
Table Mylan Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
Table Mylan Drugs for Herpes Labialis (Oral Herpes) Product
Table Mylan Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Mylan Drugs for Herpes Labialis (Oral Herpes) Sales Market Share in 2017
Figure Global Mylan Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share in 2017
Table Cadila Headquarter, Established, Main Business and Finance Overview (2017)
Table Cadila Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
Table Cadila Drugs for Herpes Labialis (Oral Herpes) Product
Table Cadila Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Cadila Drugs for Herpes Labialis (Oral Herpes) Sales Market Share in 2017
Figure Global Cadila Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share in 2017
Table Apotex Headquarter, Established, Main Business and Finance Overview (2017)
Table Apotex Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
Table Apotex Drugs for Herpes Labialis (Oral Herpes) Product
Table Apotex Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Apotex Drugs for Herpes Labialis (Oral Herpes) Sales Market Share in 2017
Figure Global Apotex Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share in 2017
Table Daewoong Pharmaceutical Headquarter, Established, Main Business and Finance Overview (2017)
Table Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
Table Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Product
Table Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Sales Market Share in 2017
Figure Global Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share in 2017
Table Livzon Headquarter, Established, Main Business and Finance Overview (2017)
Table Livzon Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
Table Livzon Drugs for Herpes Labialis (Oral Herpes) Product
Table Livzon Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Livzon Drugs for Herpes Labialis (Oral Herpes) Sales Market Share in 2017
Figure Global Livzon Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share in 2017
Table Luoxin Headquarter, Established, Main Business and Finance Overview (2017)
Table Luoxin Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
Table Luoxin Drugs for Herpes Labialis (Oral Herpes) Product
Table Luoxin Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Luoxin Drugs for Herpes Labialis (Oral Herpes) Sales Market Share in 2017
Figure Global Luoxin Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share in 2017
Table Med shine Headquarter, Established, Main Business and Finance Overview (2017)
Table Med shine Drugs for Herpes Labialis (Oral Herpes) Production Bases, Sales Regions and Major Competitors
Table Med shine Drugs for Herpes Labialis (Oral Herpes) Product
Table Med shine Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Med shine Drugs for Herpes Labialis (Oral Herpes) Sales Market Share in 2017
Figure Global Med shine Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share in 2017
Table Bayer (Campho Phenique)
Table Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes)
Table Blistex
Table Blistex Drugs for Herpes Labialis (Oral Herpes)
Table Kelun Group
Table Kelun Group Drugs for Herpes Labialis (Oral Herpes)
Table Hikma
Table Hikma Drugs for Herpes Labialis (Oral Herpes)
Table Haiwang
Table Haiwang Drugs for Herpes Labialis (Oral Herpes)
Table Carmex
Table Carmex Drugs for Herpes Labialis (Oral Herpes)
Table Cipher
Table Cipher Drugs for Herpes Labialis (Oral Herpes)
Table Global Drugs for Herpes Labialis (Oral Herpes) Sales by Manufacturer (2016-2017)
Figure Global Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Manufacturer in 2016
Figure Global Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Manufacturer in 2017
Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue by Manufacturer (2016-2017)
Figure Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Manufacturer in 2016
Figure Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Manufacturer in 2017
Table Global Drugs for Herpes Labialis (Oral Herpes) Price by Manufacturer (2016-2017)
Figure Top 3 Drugs for Herpes Labialis (Oral Herpes) Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Drugs for Herpes Labialis (Oral Herpes) Manufacturer (Revenue) Market Share in 2017
Figure Global Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure Global Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2013-2018)
Table Global Drugs for Herpes Labialis (Oral Herpes) Sales by Regions (2013-2018)
Table Global Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Regions (2013-2018)
Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue by Regions (2013-2018)
Figure Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Regions in 2013
Figure Global Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Regions in 2017
Figure North America Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure North America Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2013-2018)
Figure Europe Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure Europe Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2013-2018)
Figure South America Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure South America Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2013-2018)
Figure North America Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2013-2018)
Table North America Drugs for Herpes Labialis (Oral Herpes) Sales by Countries (2013-2018)
Table North America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Countries (2013-2018)
Figure North America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Countries in 2013
Figure North America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Countries in 2017
Table North America Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries (2013-2018)
Table North America Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Countries (2013-2018)
Figure North America Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Countries in 2013
Figure North America Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Countries in 2017
Figure United States Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure Canada Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure Mexico Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Table North America Drugs for Herpes Labialis (Oral Herpes) Sales by Manufacturer (2016-2017)
Figure North America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Manufacturer in 2016
Figure North America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Manufacturer in 2017
Table North America Drugs for Herpes Labialis (Oral Herpes) Revenue by Manufacturer (2016-2017)
Figure North America Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Manufacturer in 2016
Figure North America Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Manufacturer in 2017
Table North America Drugs for Herpes Labialis (Oral Herpes) Sales by Type (2013-2018)
Table North America Drugs for Herpes Labialis (Oral Herpes) Sales Share by Type (2013-2018)
Table North America Drugs for Herpes Labialis (Oral Herpes) Revenue by Type (2013-2018)
Table North America Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Type (2013-2018)
Table North America Drugs for Herpes Labialis (Oral Herpes) Sales by Application (2013-2018)
Table North America Drugs for Herpes Labialis (Oral Herpes) Sales Share by Application (2013-2018)
Table North America Drugs for Herpes Labialis (Oral Herpes) Revenue by Application (2013-2018)
Table North America Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Application (2013-2018)
Figure Europe Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2013-2018)
Table Europe Drugs for Herpes Labialis (Oral Herpes) Sales by Countries (2013-2018)
Table Europe Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Countries (2013-2018)
Table Europe Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries (2013-2018)
Figure Europe Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Countries in 2016
Figure Europe Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Countries in 2017
Figure Germany Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure UK Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure France Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure Russia Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure Italy Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Table Europe Drugs for Herpes Labialis (Oral Herpes) Sales by Manufacturer (2016-2017)
Figure Europe Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Manufacturer in 2016
Figure Europe Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Manufacturer in 2017
Table Europe Drugs for Herpes Labialis (Oral Herpes) Revenue by Manufacturer (2016-2017)
Figure Europe Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Manufacturer in 2016
Figure Europe Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Manufacturer in 2017
Table Europe Drugs for Herpes Labialis (Oral Herpes) Sales by Type (2013-2018)
Table Europe Drugs for Herpes Labialis (Oral Herpes) Sales Share by Type (2013-2018)
Table Europe Drugs for Herpes Labialis (Oral Herpes) Revenue by Type (2013-2018)
Table Europe Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Type (2013-2018)
Table Europe Drugs for Herpes Labialis (Oral Herpes) Sales by Application (2013-2018)
Table Europe Drugs for Herpes Labialis (Oral Herpes) Sales Share by Application (2013-2018)
Table Europe Drugs for Herpes Labialis (Oral Herpes) Revenue by Application (2013-2018)
Table Europe Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Application (2013-2018)
Figure Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales by Countries (2013-2018)
Table Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Countries 2017
Table Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries (2013-2018)
Figure Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Countries 2017
Figure China Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure Japan Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure Korea Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure India Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure Southeast Asia Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Table Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales by Type (2013-2018)
Table Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales Share by Type (2013-2018)
Table Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue by Type (2013-2018)
Table Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Type (2013-2018)
Table Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales by Application (2013-2018)
Table Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Sales Share by Application (2013-2018)
Table Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue by Application (2013-2018)
Table Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Application (2013-2018)
Figure South America Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2013-2018)
Table South America Drugs for Herpes Labialis (Oral Herpes) Sales by Countries (2013-2018)
Table South America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Countries (2013-2018)
Figure South America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Countries in 2017
Table South America Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries (2013-2018)
Table South America Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Countries (2013-2018)
Figure South America Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Countries in 2017
Figure Brazil Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure Argentina Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure Colombia Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Table South America Drugs for Herpes Labialis (Oral Herpes) Sales by Manufacturer (2016-2017)
Figure South America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Manufacturer in 2016
Figure South America Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Manufacturer in 2017
Table South America Drugs for Herpes Labialis (Oral Herpes) Revenue by Manufacturer (2016-2017)
Figure South America Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Manufacturer in 2016
Figure South America Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Manufacturer in 2017
Table South America Drugs for Herpes Labialis (Oral Herpes) Sales by Type (2013-2018)
Table South America Drugs for Herpes Labialis (Oral Herpes) Sales Share by Type (2013-2018)
Table South America Drugs for Herpes Labialis (Oral Herpes) Revenue by Type (2013-2018)
Table South America Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Type (2013-2018)
Table South America Drugs for Herpes Labialis (Oral Herpes) Sales by Application (2013-2018)
Table South America Drugs for Herpes Labialis (Oral Herpes) Sales Share by Application (2013-2018)
Table South America Drugs for Herpes Labialis (Oral Herpes) Revenue by Application (2013-2018)
Table South America Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Application (2013-2018)
Figure Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales by Countries (2013-2018)
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Countries in 2017
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue by Countries (2013-2018)
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Countries in 2013
Figure Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Countries in 2017
Figure Saudi Arabia Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure UAE Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure Egypt Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure Nigeria Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Figure South Africa Drugs for Herpes Labialis (Oral Herpes) Sales and Growth Rate (2013-2018)
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales by Type (2013-2018)
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales Share by Type (2013-2018)
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue by Type (2013-2018)
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Type (2013-2018)
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales by Application (2013-2018)
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Sales Share by Application (2013-2018)
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue by Application (2013-2018)
Table Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Application (2013-2018)
Table Global Drugs for Herpes Labialis (Oral Herpes) Sales by Type (2013-2018)
Table Global Drugs for Herpes Labialis (Oral Herpes) Sales Share by Type (2013-2018)
Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue by Type (2013-2018)
Table Global Drugs for Herpes Labialis (Oral Herpes) Revenue Share by Type (2013-2018)
Figure Global Aciclovir Sales Growth (2013-2018)
Figure Global Aciclovir Price (2013-2018)
Figure Global Valacyclovir Sales Growth (2013-2018)
Figure Global Valacyclovir Price (2013-2018)
Figure Global Famciclovir Sales Growth (2013-2018)
Figure Global Famciclovir Price (2013-2018)
Figure Global Docosanol Sales Growth (2013-2018)
Figure Global Docosanol Price (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Other Price (2013-2018)
Table Global Drugs for Herpes Labialis (Oral Herpes) Sales by Application (2013-2018)
Table Global Drugs for Herpes Labialis (Oral Herpes) Sales Share by Application (2013-2018)
Figure Global External Use Sales Growth (2013-2018)
Figure Global Oral Sales Growth (2013-2018)
Figure Global Injection Sales Growth (2013-2018)
Figure Global Drugs for Herpes Labialis (Oral Herpes) Sales, Revenue and Growth Rate (2018-2023)
Table Global Drugs for Herpes Labialis (Oral Herpes) Sales Forecast by Regions (2018-2023)
Table Global Drugs for Herpes Labialis (Oral Herpes) Market Share Forecast by Regions (2018-2023)
Figure North America Sales Drugs for Herpes Labialis (Oral Herpes) Market Forecast (2018-2023)
Figure Europe Sales Drugs for Herpes Labialis (Oral Herpes) Market Forecast (2018-2023)
Figure Asia-Pacific Sales Drugs for Herpes Labialis (Oral Herpes) Market Forecast (2018-2023)
Figure South America Sales Drugs for Herpes Labialis (Oral Herpes) Market Forecast (2018-2023)
Figure Middle East and Africa Sales Drugs for Herpes Labialis (Oral Herpes) Market Forecast (2018-2023)
Table Global Drugs for Herpes Labialis (Oral Herpes) Sales Forecast by Type (2018-2023)
Table Global Drugs for Herpes Labialis (Oral Herpes) Market Share Forecast by Type (2018-2023)
Table Global Drugs for Herpes Labialis (Oral Herpes) Sales Forecast by Application (2018-2023)
Table Global Drugs for Herpes Labialis (Oral Herpes) Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
